# Pliant Therapeutics, Inc.: Form DEF 14A, filed Apr 22, 2024

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: DEF 14A
- Filed: 2024-04-22
- Accepted by EDGAR: Apr 22, 2024, 20:58 ET
- Period: 2023-12-31
- Accession: 0001746473-24-000057
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000174647324000057/plrx-20240422.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000174647324000057/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000174647324000057/plrx-20240422.htm

Filed Apr 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001746473-24-000057. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
